- Home
- CCEL vs LVTX Comparison
CCEL vs LVTX Comparison
Compare CCEL & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- LVTX
- Stock Information
- Founded
- CCEL 1989
- LVTX 2016
- Country
- CCEL United States
- LVTX Netherlands
- Employees
- CCEL N/A
- LVTX N/A
- Industry
- CCEL Managed Health Care
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- LVTX Health Care
- Exchange
- CCEL Nasdaq
- LVTX Nasdaq
- Market Cap
- CCEL 50.0M
- LVTX 25.3M
- IPO Year
- CCEL 1997
- LVTX 2021
- Fundamental
- Price
- CCEL $7.79
- LVTX $1.03
- Analyst Decision
- CCEL
- LVTX Buy
- Analyst Count
- CCEL 0
- LVTX 3
- Target Price
- CCEL N/A
- LVTX $3.33
- AVG Volume (30 Days)
- CCEL 12.6K
- LVTX 172.5K
- Earning Date
- CCEL 12-31-2024
- LVTX 12-10-2024
- Dividend Yield
- CCEL 3.19%
- LVTX N/A
- EPS Growth
- CCEL N/A
- LVTX N/A
- EPS
- CCEL N/A
- LVTX N/A
- Revenue
- CCEL $31,838,476.00
- LVTX $7,345,000.00
- Revenue This Year
- CCEL $3.97
- LVTX N/A
- Revenue Next Year
- CCEL $0.91
- LVTX N/A
- P/E Ratio
- CCEL N/A
- LVTX N/A
- Revenue Growth
- CCEL 1.95
- LVTX N/A
- 52 Week Low
- CCEL $4.47
- LVTX $0.96
- 52 Week High
- CCEL $9.50
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- CCEL 43.85
- LVTX 32.44
- Support Level
- CCEL $7.60
- LVTX $0.96
- Resistance Level
- CCEL $9.10
- LVTX $1.95
- Average True Range (ATR)
- CCEL 0.25
- LVTX 0.16
- MACD
- CCEL -0.14
- LVTX -0.05
- Stochastic Oscillator
- CCEL 15.08
- LVTX 6.55
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.